Details of Disease

General Information of Disease (ID: DISFGEKX)

• Disease Name: Acute pain
• Disease Class: MG31: Acute pain
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISFGEKX: Acute pain
• ICD Code:
  ICD-11: ICD-11: MG31
  ICD-10: ICD-10: R52.0
  ICD-9: ICD-9: 338,780
  Expand ICD-9: 338780
• Disease Identifiers:
  MESH ID: D059787
  MedGen ID: 104540
  SNOMED CT ID: 274663001

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 4 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Chlorzoxazone	DMCYVDT	Approved	Small molecular drug	[1]
Magnesium Sulfate	DMVEK07	Approved	Small molecular drug	[2]
Oliceridine	DM6MDCF	Approved	Small molecular drug	[3]
Tapentadol hydrochloride	DMXLSH3	Approved	Small molecular drug	[4]

This Disease is Treated as An Indication in 1 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Floctafenine	DMD1HLC	Withdrawn from market	Small molecular drug	[5]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2322).
• [2] Emerging drugs for acute ischemic stroke. Expert Opin Emerg Drugs. 2009 Mar;14(1):33-42.
• [3] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
• [4] 2008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6.
• [5] Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial). Trials. 2020 Oct 13;21(1):846.